Marion Peters

Dr. Marion Peters is a Professor of Medicine at the University of California San Francisco (UCSF) School of Medicine, where she has been a prominent researcher in hepatology and viral hepatitis for several decades. She has served as Principal Investigator and Co-Principal Investigator on numerous NIH-funded research projects, including the UCSF Liver Center and the NRSA Hepatology Training Grant.

Dr. Peters received her medical education at Melbourne University Medical School in Australia, earning her M.B.B.S. in 1972, followed by her M.D. in Medicine/Immunology from Melbourne University in 1991. Her clinical training included St. Vincent's Hospital Medical School in Melbourne.

Her research focuses on viral hepatitis, particularly hepatitis B and C, with special emphasis on coinfection with HIV. Dr. Peters has made significant contributions to understanding the epidemiology, treatment, and outcomes of hepatitis in the context of HIV coinfection, with particular attention to special populations including women and those with advanced liver disease.

Dr. Peters' extensive publication record demonstrates evolving research interests from early work on intestinal immune responses in inflammatory bowel disease to her current focus on hepatitis B and C, particularly in the context of HIV coinfection. Her recent work has examined treatment outcomes with direct-acting antivirals, hepatocellular carcinoma risk, and special considerations for women and pregnant individuals with viral hepatitis.

• Honors in Medicine, Pathology, Obstetrics, & Gynecology
• Burroughs Wellcome Young Investigator in Virology

Throughout her career, Dr. Peters has secured substantial NIH funding for hepatitis research, serving as Principal Investigator on multiple R01 grants and as Co-Principal Investigator on training grants. Her work has involved extensive collaboration with national and international research networks, including the AIDS Clinical Trials Group. While specific student mentorship is not detailed in the provided information, her role as Co-Principal Investigator on training grants suggests significant involvement in mentoring the next generation of hepatology researchers.

Dr. Peters is actively involved in the UCSF Liver Center and has contributed to national guidelines for hepatitis B management. Her research often focuses on clinical cohorts across North America and internationally, addressing critical questions in hepatitis therapeutics and outcomes.